-8.6%
QXO vs GSK
+114.6%
-123.2%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.3% | -1.0% | -2.3% | -3.1% |
| 7D | -8.7% | -5.4% | -3.3% | -7.9% |
| 30D | -21.0% | -4.6% | -16.4% | -20.4% |
| 3M | -18.4% | -5.1% | -13.3% | -17.7% |
| 6M | -43.0% | -11.4% | -31.6% | -41.9% |
| YTD | -36.3% | +0.7% | -37.0% | -36.1% |
| 1Y | -42.8% | +23.0% | -65.8% | -44.1% |
| 3Y | -45.8% | +48.0% | -93.7% | -48.8% |
| 5Y | -70.8% | +48.2% | -119.0% | -72.7% |
| 10Y | +36.3% | +80.0% | -43.7% | +21.0% |
| All | -8.6% | +114.6% | -123.2% | -20.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling